Viewing StudyNCT05766410



Ignite Creation Date: 2024-05-06 @ 6:44 PM
Last Modification Date: 2024-10-26 @ 2:53 PM
Study NCT ID: NCT05766410
Status: RECRUITING
Last Update Posted: 2023-03-16
First Post: 2023-02-03

Brief Title: A Randomized Study Comparing the Immune Modulation Effect of Ribociclib Palbociclib and Abemaciclib in ERHER2- EBC
Sponsor: National Taiwan University Hospital
Organization: National Taiwan University Hospital

Conditions & Keywords Data

Conditions:
Name
Breast Cancer
Hormone Receptor-positive Breast Cancer
Hormone Therapy
Keywords:
Name View
Hormone Receptor-positive Breast Cancer View
CDK4 6 inhibitor View
Neoadjuvant therapy View
Hormone therapy View